Nivolumab induced hypophysitis in an advanced RCC patient
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552211072212
Abstract: Introduction Immune checkpoint inhibitors (ICIs) are being commonly used to treat solid tumours such as renal cell carcinoma. Hypophysitis is an acute or chronic inflammation of the pituitary gland and nivolumab or pembrolizumab induced hypophysitis… read more here.
Keywords: induced hypophysitis; patient; hypophysitis advanced; nivolumab induced ... See more keywords